No Data
Express News | Alzamend Neuro Inc: Both Treatments Had No Negative Impact on Mice's Body Weight or Clinical Signs During Treatment Period
Express News | Alzamend Neuro Inc: At a Low Dose, Al001 Evidenced Consistently Higher Lithium Concentrations Than Lithium Carbonate Within Critical Brain Regions
Alzamend Neuro Announces Full Data Set From Its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures Between AL001 and Lithium Carbonate in Alzheimer's Transgenic Mice
Express News | Ascendiant Capital Maintains Buy on Alzamend Neuro, Lowers Price Target to $35
Alzamend Neuro Analyst Ratings
Express News | Alzamend Neuro Inc - to Initiate Five Clinical Trials Based on Study Results
No Data
No Data
